Clinical trial
Danish Carvedilol Study in Portal Hypertension
NCT00493480 · Hvidovre University Hospital, Other · Completed
Key facts
| NCT number | NCT00493480 |
|---|---|
| Title | Danish Carvedilol Study in Portal Hypertension |
| Official title | Danish Carvedilol Study in Portal Hypertension. Carvedilol in the Prevention of Bleeding in Portal Hypertension and Esophageal Varices |
| Acronym | DACAPO |
| Lead sponsor | Hvidovre University Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cirrhosis, Portal Hypertension |
| Intervention type | Drug |
| Interventions | carvedilol, propranolol |
| Enrollment | 40 |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 28, 2007 |
| Last update posted | Aug 10, 2009 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: